Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
7.00
0.00 (-0.03%)
Sep 8, 2026, 3:03 PM EDT - Market open
Cytosorbents Revenue
Cytosorbents had revenue of $9.63M in the quarter ending June 30, 2026, with 0.17% growth. This brings the company's revenue in the last twelve months to $37.22M, up 3.07% year-over-year. In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.12% growth.
Revenue (ttm)
$37.22M
Revenue Growth
+3.07%
P/S Ratio
0.59
Revenue / Employee
$288,496
Employees
129
Market Cap
21.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.06M | 1.47M | 4.12% |
| Dec 31, 2024 | 35.60M | 4.51M | 14.51% |
| Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
| Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
| Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
| Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
| Dec 31, 2019 | 24.95M | 2.45M | 10.87% |
| Dec 31, 2018 | 22.50M | 7.35M | 48.53% |
| Dec 31, 2017 | 15.15M | 5.62M | 59.02% |
| Dec 31, 2016 | 9.53M | 4.74M | 98.84% |
| Dec 31, 2015 | 4.79M | 668.79K | 16.22% |
| Dec 31, 2014 | 4.12M | 1.70M | 70.18% |
| Dec 31, 2013 | 2.42M | 1.08M | 80.40% |
| Dec 31, 2012 | 1.34M | 1.31M | 3,622.31% |
| Dec 31, 2011 | 36.08K | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Nortech Systems | 124.65M |
| TELA Bio | 79.91M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| Elutia | 12.14M |
| iTonic Holdings | 523.03K |
CTSO News
- 3 days ago - CytoSorbents trading halted, news pending - TheFly
- 4 days ago - CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - Newsfile Corp
- 5 days ago - CytoSorbents announces 1-for-20 reverse stock split - TheFly
- 5 days ago - CytoSorbents Announces Reverse Stock Split - PRNewsWire
- 6 days ago - CytoSorbents announces real-world data using CytoSorb - TheFly
- 6 days ago - CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings - PRNewsWire
- 26 days ago - Cytosorbents Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Cytosorbents Slides: Investor presentation - Filings